- 4th Floor, Royal Arcade Raghunathpur, Nandankanan Road, Bhubaneswar, 751024
- +91 89174 20936
- contact@drrajeebjena.com
When pregnancy screening or an ultrasound raises concern about a possible genetic, chromosomal or fetal condition, amniocentesis in Bhubaneswar or chorionic villus sampling (CVS) may be considered to obtain more definitive diagnostic information. These are invasive prenatal diagnostic procedures performed under ultrasound guidance and are considered based on the pregnancy history, gestational age, screening results, ultrasound findings and individual clinical circumstances.
Dr. Rajeeb Jena provides Fetal Medicine & Gynae care, high-risk pregnancy consultation, advanced pregnancy ultrasound and fetal imaging, fetal testing and fetal therapy in Bhubaneswar. Pre-procedure counselling helps parents understand why testing has been suggested, what information it may provide, potential risks, alternatives and what happens after the procedure.
Being advised to undergo an invasive prenatal test can naturally cause anxiety. Understanding the purpose of the test and discussing its potential benefits and risks with a fetal medicine specialist can help you make an informed decision.
Invasive prenatal diagnostic procedures involve obtaining a small sample of fetal-related tissue or fluid during pregnancy for laboratory analysis. Unlike screening tests, these procedures can provide more definitive information about particular genetic or chromosomal conditions, depending on the sample and laboratory tests performed.
Common prenatal diagnostic procedures in Bhubaneswar include:
These procedures are not required in every pregnancy. The decision depends on the clinical indication and should be made after appropriate counselling.
Before recommending an invasive test, the healthcare team may consider:
Invasive prenatal diagnosis in Bhubaneswar may be discussed when there is a higher-than-expected possibility of a genetic or chromosomal condition or when an ultrasound identifies a finding requiring further evaluation.
Possible situations include:
A recommendation for diagnostic testing does not mean that the fetus definitely has a genetic condition. The purpose of diagnostic testing is to obtain additional information when a definitive diagnosis may be clinically useful.
Amniocentesis is a prenatal diagnostic procedure in which a small amount of amniotic fluid is obtained using a thin needle under ultrasound guidance. The fluid contains fetal cells and other biological information that may be analyzed for selected genetic or chromosomal conditions.
The specific laboratory investigations depend on the reason for testing and may include chromosome analysis or other genetic tests where clinically appropriate.
Amniocentesis is generally performed later in pregnancy than CVS. Current clinical guidance commonly places amniocentesis after approximately 15 weeks of pregnancy, although the exact timing depends on the clinical circumstances and test required.
Patients commonly search for when is amniocentesis done after receiving a high-risk screening result.
Amniocentesis is generally considered after the first trimester when diagnostic information is required. It may be discussed following:
For example, amniocentesis after a high-risk double marker may be discussed depending on the complete clinical assessment, ultrasound findings and other available screening information.
Before the procedure, ultrasound is used to assess the pregnancy and identify an appropriate location for sampling.
During the amniocentesis procedure, a thin needle is carefully introduced through the mother’s abdomen under ultrasound guidance to obtain a small amount of amniotic fluid. The sample is then sent to a laboratory for the requested genetic or chromosomal analysis.
The exact laboratory testing depends on the clinical question. Depending on the indication, testing may include chromosome analysis such as a karyotype, rapid testing such as FISH, or other genetic investigations such as microarray, when clinically appropriate.
Amniocentesis is an invasive procedure and is therefore not completely risk-free. Potential complications may include bleeding, infection, fluid leakage or pregnancy loss, with the level of risk depending on factors such as gestational age, clinical circumstances and procedural factors.
The NHS currently describes a miscarriage risk of approximately 1 in 200 after amniocentesis, although individual risk can vary and should be discussed with the treating specialist.
This is why amniocentesis counselling in Bhubaneswar is an important part of the process before giving informed consent.
Chorionic Villus Sampling (CVS) is a prenatal diagnostic procedure in which a small sample of chorionic villi, which are part of the developing placenta, is collected for genetic testing.
CVS can provide diagnostic genetic information earlier in pregnancy than amniocentesis in appropriate cases. Current clinical resources generally describe CVS as being performed around 11–13 weeks or, depending on the clinical setting, within the broader 11–14-week period.
Patients searching for CVS test at 11 to 13 weeks are generally asking whether an early diagnostic test can be considered after a concerning screening or clinical finding.
CVS may be considered when there is a known or suspected risk of a genetic or chromosomal condition and diagnostic information is required. Possible reasons include:
The exact timing and suitability of CVS depend on gestational age, placental location, suspected condition and individual clinical factors.
Chorionic villus sampling is performed under ultrasound guidance. Depending on the pregnancy and placental location, the sample may be obtained through the cervix or through the mother’s abdomen.
The sample is then sent for appropriate laboratory testing.
A common question is the amniocentesis vs CVS difference.
| Feature | Amniocentesis | CVS |
|---|---|---|
| Sample | Amniotic fluid | Chorionic villi from placenta |
| Timing | Generally later in pregnancy | Generally earlier in pregnancy |
| Procedure | Thin needle through abdomen under ultrasound guidance | Transabdominal or transcervical sampling under ultrasound guidance |
| Main purpose | Diagnostic testing for selected genetic/chromosomal conditions | Diagnostic testing for selected genetic/chromosomal conditions |
| Timing advantage | Performed later | Can provide diagnostic information earlier |
| Suitability | Depends on pregnancy and clinical indication | Depends on gestational age, placenta and clinical indication |
The choice between CVS vs amniocentesis is individualized. A fetal medicine specialist can explain which procedure may be appropriate based on the pregnancy and the condition being investigated.
NIPT and invasive diagnostic procedures serve different purposes.
NIPT is a screening test that estimates the likelihood of selected chromosomal conditions. A high-risk NIPT result does not by itself confirm that the fetus has the condition.
Amniocentesis and CVS are diagnostic procedures that obtain a fetal-related sample for laboratory analysis and can provide more definitive information about specific genetic or chromosomal conditions, depending on the testing performed.
Therefore, a high-risk NIPT result may lead to a discussion about diagnostic testing rather than being treated as a definitive diagnosis.
Prenatal procedure counselling in Bhubaneswar is an important part of invasive prenatal diagnosis.
Before undergoing amniocentesis, CVS or another invasive test, parents should have an opportunity to understand:
This amniocentesis counselling consultation in Bhubaneswar can help parents understand the difference between screening and diagnosis and discuss their concerns before informed consent.
Before the procedure, the doctor may review your pregnancy history, screening reports, ultrasound findings, family history and the specific reason for diagnostic testing.
The counselling process should also provide an opportunity to discuss consent, potential risks, alternatives and what different test results could mean for your pregnancy.
Multifetal Pregnancy Reduction is a specialized procedure that may be considered in selected multiple pregnancies under specific medical circumstances.
It may be discussed when a pregnancy involves multiple fetuses and significant maternal or fetal considerations require specialist evaluation. The decision depends on factors including:
Because this is a highly individualized decision, multifetal pregnancy reduction counselling and specialist evaluation are essential. In appropriate cases, multidisciplinary consultation or referral to a tertiary-care centre may be recommended.
After an invasive prenatal procedure, patients may receive instructions regarding routine observation and symptoms that require medical attention.
Laboratory processing times vary depending on the test. Some analyses may provide preliminary information sooner, while more comprehensive genetic testing can take longer.
Once results are available, they should be interpreted alongside the ultrasound findings, family history and the reason the test was performed.
Depending on the result, follow-up may include a fetal medicine consultation, genetic counselling or further specialist assessment.
Invasive prenatal procedures are performed under ultrasound guidance by appropriately trained specialists, but no invasive medical procedure is completely free of risk.
Potential complications can include bleeding, infection, fluid leakage and pregnancy loss. The level of risk varies according to the procedure, gestational age and individual clinical circumstances.
For this reason, the potential benefits, limitations, alternatives and procedure-specific risks should be discussed before informed consent.
The information on this page is intended for general educational purposes and should not be considered a substitute for professional medical advice, diagnosis or treatment.
Invasive prenatal diagnostic procedures have specific indications, limitations and potential risks. The suitability of amniocentesis, CVS, multifetal pregnancy reduction or any other procedure depends on individual clinical circumstances.
Genetic screening results are not the same as diagnostic results. Patients should discuss the potential benefits, limitations, alternatives and risks with a qualified fetal medicine specialist before making decisions regarding prenatal testing or treatment.
Amniocentesis is a prenatal diagnostic procedure in which a small amount of amniotic fluid is obtained using a thin needle under ultrasound guidance. The sample can be analyzed for selected genetic or chromosomal conditions depending on the clinical indication.
Patients may experience discomfort, pressure or brief cramping during or after amniocentesis. Individual experiences vary, and the healthcare team can explain what to expect and provide appropriate aftercare instructions.
Amniocentesis is an established prenatal diagnostic procedure, but it is not completely risk-free. Potential risks include bleeding, infection, fluid leakage and pregnancy loss, and the individual risk should be discussed with the treating fetal medicine specialist.
The miscarriage risk varies according to individual circumstances and the way risk is estimated. Current NHS information describes a risk of approximately 1 in 200 after amniocentesis, while emphasizing that individual circumstances can alter risk.
Amniocentesis is generally performed after the first trimester, commonly from around 15 weeks onward. The exact timing depends on the clinical indication, gestational age and test being considered.
A high-risk double marker is a screening result rather than a definitive diagnosis. Depending on the complete clinical assessment, ultrasound findings and other screening information, a fetal medicine specialist may discuss further evaluation and whether diagnostic testing such as amniocentesis is appropriate.
CVS, or chorionic villus sampling, is an invasive prenatal diagnostic procedure in which a small sample of chorionic villi from the placenta is collected for genetic testing.
CVS can provide diagnostic information earlier in pregnancy than amniocentesis in appropriate cases.
CVS is generally performed around 11–13 weeks of pregnancy, although the exact timing can vary according to clinical circumstances.
CVS samples chorionic villi from the placenta, while amniocentesis samples amniotic fluid. CVS is generally performed earlier in pregnancy, while amniocentesis is usually performed later.
The choice depends on gestational age, placental location, the suspected condition and the clinical indication.
CVS may cause discomfort, pressure or cramping. Individual experiences vary, and the procedure team should explain the expected sensations and aftercare before the procedure.
The time required depends on the laboratory test. Some analyses can provide preliminary information sooner, while comprehensive genetic testing may take longer.
Multifetal pregnancy reduction is a specialized procedure that may be considered in selected multiple pregnancies under specific medical circumstances. Decisions depend on factors such as the number of fetuses, chorionicity, gestational age, fetal findings and maternal health.
It may be considered in selected high-order or multiple pregnancies where significant maternal or fetal considerations require specialist evaluation. It is a highly individualized decision requiring detailed counselling and specialist assessment.
After an invasive prenatal procedure, the treating team will provide individualized instructions regarding observation, activity and symptoms that require medical attention. Follow the specific post-procedure advice given by your healthcare team rather than assuming that bed rest is required for everyone.
Useful questions include:
Preparation depends on the individual procedure and clinical circumstances. Before amniocentesis, your doctor will review relevant pregnancy information, ultrasound findings and screening or genetic results and explain the procedure, risks, alternatives and follow-up.
Yes. If you have received a high-risk screening result, abnormal NIPT, concerning ultrasound finding or have a relevant family or previous pregnancy history, a prenatal diagnosis counselling consultation in Bhubaneswar can help determine whether invasive diagnostic testing should be considered.
The consultation fee and total cost can vary depending on the type of consultation, procedure and laboratory testing required. Contact the clinic directly for the current prenatal diagnosis consultation fee and procedure-related costs.
You can contact Dr. Rajeeb Jena’s clinic to discuss your pregnancy, screening or ultrasound findings and book a prenatal procedure counselling appointment in Bhubaneswar.
